Immune Repertoire Sequencing Market Share

  • Report ID: 3997
  • Published Date: Dec 20, 2024
  • Report Format: PDF, PPT

Immune Repertoire Sequencing Market Share

North American Market Forecast

North America industry is set to hold largest revenue share by 2037. This can be ascribed to the high health spending, and strong presence of market players in the region, especially in the United States and Canada. According to the Centers for Medicare & Medicaid Services (CMS), health spending in the United States grew by 9.7% in 2020, reaching a value of USD 4.1 trillion, or USD 12,530 per person. The market is also anticipated to grow with escalating demand for immunotherapy for cancer and other infectious diseases.

APAC Market Statistics

The immune repertoire sequencing market in the Asia Pacific region is estimated to observe noteworthy market demand throughout the estimated period. This can be attributed on the back of the increasing number of international collaborations for immune repertoire sequencing in the region.

In addition, the focus of countries, namely China and Japan, on the integration of new technologies in the healthcare sector is also expected to drive market growth significantly in the coming years. 

Research Nester
Get more information on this report: Request Free Sample PDF

Browse Key Market Insights with Data Illustration:


Author Credits:  Rajrani Baghel


  • Report ID: 3997
  • Published Date: Dec 20, 2024
  • Report Format: PDF, PPT

Frequently Asked Questions (FAQ)

In the year 2025, the industry size of immune repertoire sequencing is assessed at USD 1.36 billion.

The immune repertoire sequencing market size was valued at USD 1.22 billion in 2024 and is expected to reach USD 2.87 billion by 2037, expanding at around 6.8% CAGR during the forecast period i.e., between 2025-2037. The market growth is propelled by increasing number of launches of novel products, and rising government funding to improve the healthcare infrastructure.

North America industry is set to hold largest revenue share by 2037, due to high health spending, and strong presence of market players in the region.

The major players in the market are Agilent Technologies, Inc, Illumina, Inc., Pacific Biosciences of California, Inc, QIAGEN N.V., Thermo Fisher Scientific, Inc., F. Hoffmann-La Roche AG, Takara Bio, Inc, Oxford Nanopore Technologies, Ltd, BGI Group, Atreca Inc
Inquiry Before Buying Request Free Sample
logo
  GET A FREE SAMPLE

FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.

 Request Free Sample Copy

Have questions before ordering this report?

Inquiry Before Buying
Inquiry Before Buying Request Free Sample